A Trial of Tisotumab Vedotin in Cervical Cancer

NCT03438396 · clinicaltrials.gov ↗
PHASE2
Phase
COMPLETED
Status
102
Enrollment
INDUSTRY
Sponsor class

Conditions

Interventions

Sponsor

Seagen Inc.

Collaborators